Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7

Journal of Cellular Biochemistry

Volumn 95, Issue 1, 2005, Pages 1-16

  Zhao, Ming ^a   Zhao, Zhuoran ^a   Koh, Jeong Tae ^b   Jin, Taocong ^a   Franceschi, Renny T ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Chonnam National University   (South Korea)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

BMP; Bone regeneration

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COMPLEMENTARY DNA; OSTEOGENIC PROTEIN 1; BONE MORPHOGENETIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; EMBRYO; FIBROBLAST; FRACTURE HEALING; GENE THERAPY; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME; MOUSE; NONHUMAN; OSTEOBLAST; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; CELL LINE; FRACTURE; GENETICS; PHYSIOLOGY; TRANSPLANTATION;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

ADENOVIRIDAE; ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL LINE; FIBROBLASTS; FRACTURES, BONE; GENE THERAPY; MICE; OSTEOGENESIS;

EID: 23844546987     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20411     Document Type: Article

References (52)

1. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K. 2001. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sc 114:1483-1489.
2. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S, Fujisawa Y. 1995. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210:670-677.
3. Baltzer AW, Lattermann C, Whalen JD, Ghivizzani S, Wooley P, Krauspe R, Robbins PD, Evans CH. 2000a. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop 379:8120-8125.
4. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M, Ghivizzani SC, Robbins PD, Evans CH. 2000b. Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7:734-739.
5. Bonadio J, Smiley E, Patil P, Goldstein S. 1999. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration [see comments]. Nat Med 5:753-759.
6. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85A:1544-1552.
7. Cho TJ, Gerstenfeld LC, Einhorn TA. 2002. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520.
8. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. 2000. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71:1241-1257.
9. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [see comments]. Cell 89:747-754.
10. Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. 2000. Gene therapy for bone formation: In vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78:476-486.
11. Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, Wang D. 2004. Gene therapy approaches for bone regeneration. Cells Tissues Organs 176:95-108.
12. Geesink RG, Hoefnagels NH, Bulstra SK. 1999. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81:710-718.
13. Giannobile WV, Ryan S, Shih MS, Su DL, Kaplan PL, Chan TC. 1998. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol 69:129-137.
14. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S. 2002. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642.
15. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842-1849.
16. Hazama M, Aono A, Ueno N, Fujisawa Y. 1995. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun 209:859-866.
17. Heinonen JK, Lahti RJ. 1981. A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase. Anal Biochem 113:313-317.
18. Hogan BL. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
19. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, Wozney JM. 1996. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13:291-300.
20. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. 1990. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299.
21. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. [Published erratum appears in J Cell Biol 1995 Feb;128(4):following 713]. J Cell Biol 127: 1755-1766.
22. King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. 1997. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 76:1460-1470.
23. Kirker-Head CA. 2000. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 43:65-92.
24. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. 2000. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo [In Process Citation]. Hum Gene Ther 11:1201-1210.
25. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON. 1999. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81:905-917.
26. Lyons KM, Hogan BL, Robertson EJ. 1995. Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 50:71-83.
27. Manolagas SC, Burton DW, Deftos LJ. 1981. 1,25-Dihydroxyvitamin D stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7115-7117.
28. Mason JM, Grande DA, Barcia M, Grant R, Pergolizzi RG, Breitbart AS. 1998. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: Potential utility in gene therapy for osteochondral repair. Gene Ther 5:1098-1104.
29. Musgrave DS, Bosch P, Lee JY, Pelinkovic D, Ghivizzani SC, Whalen J, Niyibizi C, Huard J. 2000. Ex vivo gene therapy to produce bone using different cell types. Clin Orthop 378:290-305.
30. Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T. 1997. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 272:22046-22052.
31. Nishimatsu S, Thomsen GH. 1998. Ventral mesoderm induction and patterning by bone morphogenetic protein heterodimers in Xenopus embryos. Mech Dev 74:75-88.
32. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K. 1996. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352.
33. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338.
34. Nohe A, Keating E, Knaus P, Petersen NO. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299.
35. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H. 1999. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol 277:C132-C138.
36. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751-759.
37. Puchtler H, Meloan SN, Terry MS. 1969. On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 17:110-124.
38. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J. 1998. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 63:357-360.
39. Rutherford RB, Moalli M, Franceschi RT, Wang D, Gu K, Krebsbach PH. 2002. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 8:441-452.
40. Sampath TK, Coughlin JE, Whetstone RM, Banach D, Corbett C, Ridge RJ, Ozkaynak E, Oppermann H, Rueger DC. 1990. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 265:13198-13205.
41. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
42. Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
43. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269: 16985-16988.
44. Winn SR, Hu Y, Sfeir C, Hollinger JO. 2000. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 42:121-138.
45. Wozney JM, Rosen V. 1998. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 346:26-37.
46. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
47. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. 2002. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
48. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725-727.
49. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K. 1995. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130: 217-226.
50. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. 2003, In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18:705-715.
51. Zhou S, Glowacki J, Yates KE. 2004. Comparison of TGF-beta/BMP pathways signaled by demineralized bone powder and BMP-2 in human dermal fibroblasts. J Bone Miner Res 19:1732-1741.
52. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. 2004. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 19:2021-2032.